Diagnostic Robotics, a leading provider of Artificial Intelligence & Care Management solutions for Healthcare plans and providers, today announced the closing of a $45M Series B funding round led by StageOne investors, with participation from Mayo Clinic, thus becoming a Mayo Clinic Platform portfolio company. Technion - Israel Institute of Technology, as well as other existing investors. Strategic angel investor Bradley Bloom, co-founder of Berkshire Partners, participated in this funding round as well.

Diagnostic Robotics has brought together the leading artificial intelligence researchers to create powerful AI solutions for healthcare institutions and organizations. Trained on tens of billions of claims data points and nearly 100 million patient visits, Diagnostic Robotics' solutions are actively in use at several leading health plans around the globe. The company's systems integrate seamlessly into major touchpoints along the patient journey, providing high-value decision support while slashing administrative burdens, massively reducing cost of care, and improving patient experiences.